真实世界 TIL（肿瘤浸润淋巴细胞）治疗转移性黑色素瘤：高剂量 IL-2 期间的治疗实施、免疫重建与心脏监测
Real-World Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Treatment Delivery, Immune Reconstitution, and Cardiac Monitoring During Hig
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
FRONTIER PAPERS
前沿论文 10
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序（权威性 + 新鲜度）。
Lifileucel：为晚期黑色素瘤新疗法带来曙光
Lifileucel: Shedding Light on a New Treatment for Advanced Melanoma.
FDA 批准摘要：Lifileucel 用于既往接受过抗 PD-1 为基础免疫治疗不可切除或转移性黑色素瘤
FDA Approval Summary: Lifileucel for Unresectable or Metastatic Melanoma Previously Treated with an Anti-PD-1-Based Immunotherapy.
进入 TIL（肿瘤浸润淋巴细胞）细胞疗法创新的新时代
Entering a new era of tumor-infiltrating lymphocyte cell therapy innovation.
社论：自体 TIL（肿瘤浸润淋巴细胞）过继细胞治疗的首个监管批准——Lifileucel（Amtagvi）
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) - Lifileucel (Amtagvi).
共 10 条